Welcome to
Support Path

We’re here to help.

Support Path is a program that can help patients get started on Gilead and Asegua treatments.

Call now to connect live with a Support Path Program Navigator at
1-855-7-MYPATH (1-855-769-7284) Monday – Friday, 9 am to 8 pm ET.

EPCLUSA® (sofosbuvir 400 mg/velpatasvir 100 mg), HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg), VOSEVI® (sofosbuvir 400 mg/velpatasvir 100 mg/voxilaprevir 100 mg), SOVALDI® (sofosbuvir 400 mg), Authorized Generic of EPCLUSA® (sofosbuvir 400 mg/velpatasvir 100 mg), Authorized Generic of HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg), VEMLIDY® (tenofovir alafenamide 25 mg)

Patients

Connect for support to get
started on treatment

Providers

Help patients understand coverage
and get started on treatment

Pharmacies

Help patients get started on treatment
Please see Important Facts about EPCLUSA, HARVONI, VEMLIDY, and VOSEVI, and Patient Information for SOVALDI, including Important Warning. Please see full Prescribing Information for sofosbuvir/velpatasvir and ledipasvir/sofosbuvir, including Important Warning and Patient Information.
Gilead Privacy Policy | Gilead Terms of Use | Gilead.com | Contact Us
Asegua Privacy Policy | Asegua Terms of Use | Asegua.com | Contact Us
Gilead corporate logo Asegua logo

Photos not of actual patients.
EPCLUSA, the EPCLUSA logo, HARVONI, the HARVONI logo, SOVALDI, the SOVALDI logo, VEMLIDY, the VEMLIDY logo, VOSEVI, the VOSEVI logo, SUPPORT PATH, the SUPPORT PATH logo, GILEAD and the GILEAD logo are trademarks of Gilead Sciences, Inc., or its related companies. ASEGUA and the ASEGUA logo are trademarks of Asegua Therapeutics LLC. All other trademarks referenced herein are the property of their respective owners.

©2021 Gilead Sciences, Inc. All rights reserved. US-PTFC-0010 12/21